In this study, we set out to create biological assay descriptions suitable for data curation and modeling purposes. To this end, we examined various methods for incorporating biological assay context, analyzed the difference between biological assays, and evaluated the use of assay context for PCM models on representative sets of target groups. The findings contribute to the incorporation of biological assay context into the bioactivity model and adaptation of this context by the modeler.